Institutes of Evolution, Immunology and Infection Research, School of Biological Sciences, King's Buildings, University of Edinburgh, West Mains Road, Edinburgh EH9 3JT, UK.
BMC Immunol. 2010 Feb 17;11:6. doi: 10.1186/1471-2172-11-6.
Antibody isotype responses can be useful as indicators of immune bias during infection. In studies of parasite co-infection however, interpretation of immune bias is complicated by the occurrence of cross-reactive antibodies. To confidently attribute shifts in immune bias to the presence of a co-infecting parasite, we suggest practical approaches to account for antibody cross-reactivity. The potential for cross-reactive antibodies to influence disease outcome is also discussed.
Utilising two murine models of malaria-helminth co-infection we analysed antibody responses of mice singly- or co-infected with Plasmodium chabaudi chabaudi and Nippostrongylus brasiliensis or Litomosoides sigmodontis. We observed cross-reactive antibody responses that recognised antigens from both pathogens irrespective of whether crude parasite antigen preparations or purified recombinant proteins were used in ELISA. These responses were not apparent in control mice. The relative strength of cross-reactive versus antigen-specific responses was determined by calculating antibody titre. In addition, we analysed antibody binding to periodate-treated antigens, to distinguish responses targeted to protein versus carbohydrate moieties. Periodate treatment affected both antigen-specific and cross-reactive responses. For example, malaria-induced cross-reactive IgG1 responses were found to target the carbohydrate component of the helminth antigen, as they were not detected following periodate treatment. Interestingly, periodate treatment of recombinant malaria antigen Merozoite Surface Protein-119 (MSP-119) resulted in increased detection of antigen-specific IgG2a responses in malaria-infected mice. This suggests that glycosylation may have been masking protein epitopes and that periodate-treated MSP-119 may more closely reflect the natural non-glycosylated antigen seen during infection.
In order to utilize antibody isotypes as a measure of immune bias during co-infection studies, it is important to dissect antigen-specific from cross-reactive antibody responses. Calculating antibody titre, rather than using a single dilution of serum, as a measure of the relative strength of the response, largely accomplished this. Elimination of the carbohydrate moiety of an antigen that can often be the target of cross-reactive antibodies also proved useful.
抗体同种型反应可作为感染过程中免疫偏倚的有用指标。然而,在寄生虫混合感染的研究中,由于存在交叉反应性抗体,免疫偏倚的解释变得复杂。为了有信心地将免疫偏倚的变化归因于合并感染寄生虫的存在,我们建议采用实用方法来考虑抗体的交叉反应。还讨论了交叉反应性抗体影响疾病结果的潜力。
我们利用两种疟疾-蠕虫混合感染的小鼠模型,分析了单独或同时感染伯氏疟原虫和巴西旋毛虫或Sigmodontis 利什曼原虫的小鼠的抗体反应。我们观察到了针对两种病原体的交叉反应性抗体反应,无论在 ELISA 中使用粗寄生虫抗原制剂还是纯化的重组蛋白,都会出现这种反应。在对照小鼠中没有观察到这些反应。通过计算抗体滴度来确定交叉反应性与抗原特异性反应的相对强度。此外,我们分析了抗体与过碘酸盐处理抗原的结合,以区分针对蛋白质与碳水化合物部分的反应。过碘酸盐处理影响抗原特异性和交叉反应性反应。例如,发现疟疾诱导的交叉反应性 IgG1 反应针对蠕虫抗原的碳水化合物成分,因为在用过碘酸盐处理后未检测到这些反应。有趣的是,过碘酸盐处理重组疟疾抗原 Merozoite Surface Protein-119(MSP-119)导致感染疟疾的小鼠中检测到更多的抗原特异性 IgG2a 反应。这表明糖基化可能掩盖了蛋白质表位,并且用过碘酸盐处理的 MSP-119 可能更接近感染期间观察到的天然非糖基化抗原。
为了在混合感染研究中将抗体同种型用作免疫偏倚的衡量标准,重要的是要将抗原特异性与交叉反应性抗体反应分开。通过计算抗体滴度(而不是使用血清的单一稀释度)作为反应相对强度的衡量标准,在很大程度上实现了这一点。消除抗原的碳水化合物部分通常也是交叉反应性抗体的靶标,这也被证明是有用的。